Different subtypes and stages of breast cancer have their unique expression of stem cell markers such as CD44, CD24 and aldehyde dehydrogenase (ALDH) [4] and the search for drugs which reduce cancer stemness is an essential investigation in drug discovery and development programs. Here, CD44 is linked to breast carcinoma.